MyoKardia Shares Rise After News of Bristol Myers Squibb Deal
October 05 2020 - 12:14PM
Dow Jones News
By Stephen Nakrosis
Shares of MyoKardia Inc. are trading higher in Monday's market,
following news the heart drug maker agreed to be acquired by
Bristol Myers Squibb in a $13.1 billion deal.
At 11:32 a.m. EDT, MyoKardia's shares were trading 58.06% higher
at $220.65. Volume at the time topped 7.7 million shares, above the
65-day average volume of 383,923.
Year to date, MyoKardia shares are up over 202%.
The two companies announced the agreement before the bell
Monday, which will see a subsidiary of Bristol Myers Squibb acquire
MyoKardia for $225 per share in an all-cash deal.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
October 05, 2020 11:59 ET (15:59 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
MyoKardia (NASDAQ:MYOK)
Historical Stock Chart
From Oct 2024 to Nov 2024
MyoKardia (NASDAQ:MYOK)
Historical Stock Chart
From Nov 2023 to Nov 2024
